ENDRA Life Sciences (NDRA) director Digiandomenico received 600 Stock Options
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Anthony Digiandomenico (director at ENDRA Life Sciences Inc., NDRA) reported that they received 600 Stock Options on Jan 2, 2024.
- Reporting person
- Digiandomenico Anthony
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 2, 2024 | Grant or award (A) | Stock OptionsOn 600 Common Stock1, 2 | +600 | - | - | 600 direct |
Holdings before and after
- Stock Options: 0 to 600 direct
Footnotes from the filing
- 1. Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy.
- 2. This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Digiandomenico report in this NDRA Form 4?
Anthony Digiandomenico (director at ENDRA Life Sciences Inc., NDRA) reported that they received 600 Stock Options on Jan 2, 2024.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for NDRA
Earlier insider filings at NDRA
- Feb 23, 2024SEC Form 4 filed by Basenese Lou
- Feb 23, 2024SEC Form 4 filed by Tokman Alexander Y
- May 22, 2023SEC Form 4 filed by Thornton Michael Milos
- May 3, 2023SEC Form 4 filed by Digiandomenico Anthony
- Feb 2, 2023SEC Form 4 filed by Basenese Lou
Keep researching NDRA
- NDRA insider tradesEvery buy and sale reported by ENDRA Life Sciences Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- NDRA financial statementsRevenue, profit, cash flow and balance sheet from ENDRA Life Sciences Inc.'s SEC filings.
Quantisnow market dataNASDAQ
NDRA
ENDRA Life Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2017
Get push alerts for NDRA
Full NDRA profile on Quantisnow Follow NDRA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time